| abstract |
Methods and compositions are provided for providing oligonucleotides that bind to a target biomarker and permit characterization of the phenotype. The target biomarker may include microcystic antigens that include microcysts derived from a variety of diseases. Characterization may include detection of a disease or disorder, diagnosis, prognosis, therapeutic diagnosis, or other characteristics. |